Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |